Xilio Therapeutics, Inc. (XLO) Misses Q1 EPS by 37c
Tweet
Share
E-mail
Get Alerts XLO Hot Sheet
Join SI Premium – FREE
Xilio Therapeutics, Inc. (NASDAQ: XLO) reported Q1 EPS of ($0.18), $0.37 worse than the analyst estimate of $0.19.
For earnings history and earnings-related data on Xilio Therapeutics, Inc. (XLO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Curl Warehouse Launches Canada's First Curl Hair Index for Curly Hair
- Paramount Skydance, Warner Bros spiking higher on volume
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
